T-box transcription factor TBX3 (TBX3)

T-box transcription factor TBX3 is a member of the T-box gene family, characterized by a conserved DNA binding domain that regulates transcription of target genes critical for development, stem cell function, and disease processes. TBX3 orchestrates complex transcriptional networks by repressing or activating promoters in a context-dependent manner, often collaborating with other transcription factors and chromatin modifiers. It is essential for limb, mammary gland, and heart development; mutations or altered expression cause Ulnar–mammary syndrome and cardiac defects. TBX3 is highly expressed in numerous aggressive cancers, where it drives proliferation, enhances metastatic potential, and perpetuates cancer stem cell populations. TBX3 exerts its effects through suppression of key tumor suppressor genes (e.g., p14^ARF^, p16^INK4a^, p21^WAF1^, PTEN), and its dysregulation is implicated in therapy resistance and poor patient outcomes. Research efforts are ongoing to target TBX3 in cancer and developmental disorders.

Other names

T-box protein 3T-box 3TBX3-ISOUMS (Ulnar–mammary syndrome gene)XHL (bladder cancer related protein XHL)TBX3+2a

Most mechanisms proposed for targeting TBX3 involve transcriptional inhibition or modulation—aimed at blocking its DNA binding, protein–protein interaction domains, or post-translational modification pathways. In oncology, the inhibition of TBX3's repression of tumor suppressor pathways (p14^ARF^/p53, p16^INK4a^/pRb, PTEN pathways) is a proposed therapeutic mechanism